| Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ε4 carriers: a review HN Yassine, MN Braskie, WJ Mack, KJ Castor, AN Fonteh, LS Schneider, ... JAMA neurology 74 (3), 339-347, 2017 | 187 | 2017 |
| Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults—a randomized clinical trial HN Yassine, CM Marchetti, RK Krishnan, TR Vrobel, F Gonzalez, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2009 | 174 | 2009 |
| ApoE4 alters ABCA1 membrane trafficking in astrocytes V Rawat, S Wang, J Sima, R Bar, O Liraz, U Gundimeda, T Parekh, ... Journal of Neuroscience 39 (48), 9611-9622, 2019 | 139 | 2019 |
| Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial IC Arellanes, N Choe, V Solomon, X He, B Kavin, AE Martinez, N Kono, ... EBioMedicine 59, 2020 | 117 | 2020 |
| APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease HN Yassine, CE Finch Frontiers in aging neuroscience 12, 150, 2020 | 117 | 2020 |
| Association of serum docosahexaenoic acid with cerebral amyloidosis HN Yassine, Q Feng, I Azizkhanian, V Rawat, K Castor, AN Fonteh, ... JAMA neurology 73 (10), 1208-1216, 2016 | 101 | 2016 |
| ABCA1‐mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer's disease HN Yassine, Q Feng, J Chiang, LM Petrosspour, AN Fonteh, HC Chui, ... Journal of the American Heart Association 5 (2), e002886, 2016 | 89 | 2016 |
| The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease HN Yassine, V Rawat, WJ Mack, JF Quinn, K Yurko-Mauro, E Bailey-Hall, ... Alzheimer's research & therapy 8, 1-10, 2016 | 86 | 2016 |
| DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA HN Yassine, E Croteau, V Rawat, JR Hibbeln, SI Rapoport, SC Cunnane, ... Alzheimer's research & therapy 9, 1-8, 2017 | 75 | 2017 |
| The use of metformin is associated with decreased lumbar radiculopathy pain A Taylor, AH Westveld, M Szkudlinska, P Guruguri, E Annabi, ... Journal of pain research, 755-763, 2013 | 74 | 2013 |
| Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group HN Yassine, C Samieri, G Livingston, K Glass, M Wagner, C Tangney, ... The Lancet Healthy Longevity 3 (7), e501-e512, 2022 | 72 | 2022 |
| Effect of APOE genotype on plasma docosahexaenoic acid (DHA), eicosapentaenoic acid, arachidonic acid, and hippocampal volume in the Alzheimer’s disease cooperative study … N Tomaszewski, X He, V Solomon, M Lee, WJ Mack, JF Quinn, ... Journal of Alzheimer's Disease 74 (3), 975-990, 2020 | 66 | 2020 |
| Mass spectrometric immunoassay and MRM as targeted MS‐based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes H Yassine, CR Borges, MR Schaab, D Billheimer, C Stump, P Reaven, ... PROTEOMICS–Clinical Applications 7 (7-8), 528-540, 2013 | 58 | 2013 |
| Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes1 [S] J Koska, H Yassine, O Trenchevska, S Sinari, DC Schwenke, FT Yen, ... Journal of lipid research 57 (5), 894-905, 2016 | 56 | 2016 |
| Proteomic and functional annotation analysis of injured peripheral nerves reveals ApoE as a protein upregulated by injury that is modulated by metformin treatment OK Melemedjian, HN Yassine, A Shy, TJ Price Molecular pain 9, 1744-8069-9-14, 2013 | 56 | 2013 |
| The association of human apolipoprotein C-III sialylation proteoforms with plasma triglycerides HN Yassine, O Trenchevska, A Ramrakhiani, A Parekh, J Koska, ... PloS one 10 (12), e0144138, 2015 | 54 | 2015 |
| Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions S Mendoza, O Trenchevska, SM King, RW Nelson, D Nedelkov, ... Journal of clinical lipidology 11 (1), 224-233. e2, 2017 | 46 | 2017 |
| Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes HN Yassine, A Belopolskaya, C Schall, CS Stump, SS Lau, PD Reaven Metabolism 63 (5), 727-734, 2014 | 43 | 2014 |
| The small HDL particle hypothesis of Alzheimer's disease AE Martinez, G Weissberger, Z Kuklenyik, X He, C Meuret, T Parekh, ... Alzheimer's & Dementia 19 (2), 391-404, 2023 | 41 | 2023 |
| Serum amyloid a truncations in type 2 diabetes mellitus HN Yassine, O Trenchevska, H He, CR Borges, D Nedelkov, W Mack, ... PloS one 10 (1), e0115320, 2015 | 37 | 2015 |